Brilinta 90 mg Tablet belongs to the antiplatelet drugs (blood thinners) primarily taken to prevent heart attack or stroke in people at high risk of heart disease. Brilinta 90 mg Tablet  helps to prevent blood clots in people with acute coronary syndrome (heart doesn't receive enough oxygen) who have had stents placed in blood vessels in their heart. A heart attack occurs when a blood clot blocks the blood flow to the heart. This blockage of arteries is often an accumulation of cholesterol, fat, and other substances, which form plaque in the arteries that feed the heart (coronary arteries). A heart attack signs include chest pain, upper body pain, sweating, nausea, fatigue, and trouble breathing.

Brilinta 90 mg Tablet contains Ticagrelor, which is a blood thinner that prevents clot formation in the blood vessels. Platelets are blood cells that stick together and block any cuts and breaks in blood vessels. But platelets can stick together inside already narrowed blood vessels to form a clot in people at risk of heart attack or stroke. The clot can stop blood from flowing to the heart or brain and cause a heart attack or stroke. Here, Brilinta 90 mg Tablet slows the blood's clotting action by making platelets less sticky.

Your doctor will advise you how often you take Brilinta 90 mg Tablet based on your medical condition. In some cases, you may experience dyspnea (shortness of breath), tightness in the chest, blurred vision, nosebleeds, dizziness, faintness, or lightheadedness. If side effects are persistent, talk to your doctor. Brilinta 90 mg Tablet may cause you to bleed more easily. You should not take Brilinta 90 mg Tablet if you have bleeding in your brain, a problem with blood flow, or any other bleeding risk factor.

Before taking the Brilinta 90 mg Tablet , let your doctor know about all your allergic or hypersensitivity reactions to medicines or food. Brilinta 90 mg Tablet should not be stopped even if you feel better without consulting your doctor, as stopping a sudden intake of Brilinta 90 mg Tablet may worsen your condition and increase the risk of a future heart attack. The patient should inform the doctor that they are taking Brilinta 90 mg Tablet before any surgery is scheduled or any new medicine is taken. Don't take Brilinta 90 mg Tablet before or after having heart bypass surgery. Before using Brilinta 90 mg Tablet , consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding.

Brilinta 90 mg Tablet is an antiplatelet (blood thinner) and plays a vital role in preventing the formation of harmful blood clots in your blood vessels. Brilinta 90 mg Tablet work by preventing platelets from sticking together, thereby decreasing the formation of harmful blood clots. Thus, it reduces the risk of heart attack, stroke, and acute coronary syndrome (heart doesn't receive enough oxygen or blood) in heart disease patients and patients who have undergone recent heart surgery with a stent.

You should avoid taking Brilinta 90 mg Tablet if you are allergic to Brilinta 90 mg Tablet or any active and inactive ingredients present in it.  Let your doctor know if you have a medical condition that causes bleeding such as hemophilia, stomach ulcer, or bleeding in your head or bowel. Caution is required before giving Brilinta 90 mg Tablet to the kidney or liver problems patients. People affected with respiratory problems like asthma, nasal polyps, or rhinitis should consult a doctor before intake of Brilinta 90 mg Tablet . Brilinta 90 mg Tablet is not recommended for the breastfeeding mother as it passes into the breast milk. The safety and effectiveness in children less than 18 years of age have not been established, so Brilinta 90 mg Tablet should not be given to them.